Encompass Health Corporation
EHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,478 | $1,458 | $1,455 | $1,405 |
| % Growth | 1.4% | 0.2% | 3.6% | – |
| Cost of Goods Sold | $785 | $831 | $825 | $819 |
| Gross Profit | $693 | $627 | $631 | $586 |
| % Margin | 46.9% | 43% | 43.3% | 41.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $56 | $74 | $67 | $69 |
| SG&A Expenses | $56 | $74 | $67 | $69 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $393 | $294 | $297 | $284 |
| Operating Expenses | $449 | $368 | $364 | $354 |
| Operating Income | $244 | $259 | $267 | $232 |
| % Margin | 16.5% | 17.8% | 18.3% | 16.5% |
| Other Income/Exp. Net | -$24 | -$22 | -$28 | -$31 |
| Pre-Tax Income | $220 | $237 | $239 | $201 |
| Tax Expense | $45 | $51 | $42 | $38 |
| Net Income | $127 | $142 | $152 | $121 |
| % Margin | 8.6% | 9.7% | 10.4% | 8.6% |
| EPS | 1.26 | 1.41 | 1.5 | 1.2 |
| % Growth | -10.6% | -6% | 25% | – |
| EPS Diluted | 1.24 | 1.39 | 1.48 | 1.18 |
| Weighted Avg Shares Out | 101 | 101 | 101 | 100 |
| Weighted Avg Shares Out Dil | 102 | 102 | 102 | 102 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $31 | $30 | $32 | $33 |
| Depreciation & Amortization | $82 | $80 | $79 | $78 |
| EBITDA | $333 | $347 | $350 | $312 |
| % Margin | 22.5% | 23.8% | 24% | 22.2% |